Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Hiring a Chief Commercial Officer for a medical device company is distinctive, because commercializing regulated medical devices, through complex sales channels, to clinical and institutional buyers, differs sharply from commercial leadership in other industries. A MedTech CCO must understand device commercialization, reimbursement, and clinical selling, so hire for genuine sector commercial experience, not general commercial pedigree.
Key Takeaways
- A MedTech CCO must understand device commercialization specifically.
- Reimbursement and market access are central to device commercial success.
- Selling to clinical and institutional buyers is distinctive.
- Match the CCO to your commercial model and stage.
- Sector commercial experience matters more than general pedigree.
Why MedTech Commercialization Is Different
Commercializing medical devices is distinctive: products are sold to clinical and institutional buyers (physicians, hospitals, health systems), success depends heavily on reimbursement and market access, sales cycles are often long and relationship-driven, and the regulatory and clinical evidence behind a device shapes what can be claimed and sold. A Chief Commercial Officer from an unrelated industry may not understand these dynamics, and a commercial approach that works elsewhere may fail in MedTech. This is why a MedTech CCO must bring genuine device-commercialization understanding, since the commercial reality of selling regulated devices to clinical buyers differs fundamentally from general commercial leadership.
Reimbursement and Market Access
A defining feature of device commercialization is reimbursement and market access: whether and how a device is reimbursed by payors profoundly shapes its commercial success, and market access, getting devices onto formularies, into health systems, and reimbursed, is often decisive. A MedTech CCO must understand reimbursement and market access deeply, since a commercially brilliant leader who does not grasp them can misjudge the entire commercial strategy. Assess the candidate’s genuine experience with device reimbursement and market access, since these are central to MedTech commercial success in a way they are not in many other industries, and a CCO who misjudges them undermines commercialization.
Clinical Selling and the Commercial Model
MedTech selling is often clinical and relationship-driven: it involves engaging physicians and clinical stakeholders, demonstrating clinical value and evidence, and navigating long, complex institutional sales cycles. The right CCO understands this clinical, evidence-based, relationship-driven commercial model, and matches your company’s specific model and stage, an early commercial-stage device company needs a different CCO than a scaled one. A CCO experienced in the clinical selling and commercial model your devices require brings capability a general commercial leader may lack. Match the CCO to your commercial model, clinical selling approach, and stage, since MedTech commercial leadership is specific to the sector’s selling reality.
What This Looks Like in Practice
A medical device company hiring a CCO looks for genuine device-commercialization experience: understanding of reimbursement and market access, clinical and institutional selling, and the specific commercial model and stage of the company. It probes real MedTech commercial results, not general commercial pedigree. It does not hire an impressive commercial leader from an unrelated industry assuming their approach will translate, or overlook the reimbursement and market-access dimension central to device success.
The Mistake Employers Keep Making
The most common mistake is hiring a commercially impressive leader from an unrelated industry, assuming strong general commercial skills will carry MedTech commercialization. But device commercialization, with its reimbursement dependence, clinical selling, and long institutional cycles, is specific, and a leader who does not understand it can misjudge the commercial strategy badly. The company mistakes general commercial excellence for device-commercialization capability, and the CCO struggles with the reimbursement, clinical, and market-access realities the sector demands.
General CCO vs MedTech CCO
| Dimension | General CCO | MedTech CCO |
|---|---|---|
| Buyers | Varies | Clinical and institutional |
| Reimbursement/market access | Often not central | Central to success |
| Selling model | Varies | Clinical, evidence-based, relationship-driven |
| Sales cycles | Varies | Often long and complex |
| Key requirement | General commercial skill | Device-commercialization experience |
The Bottom Line
A MedTech Chief Commercial Officer must understand device commercialization, reimbursement and market access, clinical selling, and the company’s specific commercial model, so hire for genuine sector commercial experience matched to your model and stage, not general commercial pedigree that may misjudge the realities of selling regulated devices to clinical buyers. Matching the person to the real demands of the role, not just a strong generalist to a title, is what separates success from expensive disappointment.
Related Reading
For more, see How to Recruit Top Talent in a Competitive MedTech Market, How to Hire a Medical Device CEO Who Understands FDA Pathways, Executive Search Strategies for MedTech Startups Scaling Post-Series B.
Frequently Asked Questions
- Q: What makes a MedTech CCO different?
- A: Device commercialization involves clinical and institutional buyers, reimbursement dependence, and long relationship-driven sales cycles, so a MedTech CCO must understand these, unlike general commercial leadership.
- Q: Why does reimbursement matter for a MedTech CCO?
- A: Because whether and how a device is reimbursed profoundly shapes its commercial success, so a CCO who does not grasp reimbursement and market access can misjudge the commercial strategy.
- Q: What is distinctive about MedTech selling?
- A: It is often clinical and evidence-based, engaging physicians and clinical stakeholders and navigating long, complex institutional sales cycles, unlike many other industries’ selling.
- Q: Can a commercial leader from another industry succeed?
- A: Only with genuine device-commercialization understanding; a leader who assumes a general commercial approach will translate may misjudge reimbursement, clinical selling, and market access.
- Q: How do I match a CCO to my company?
- A: Match them to your commercial model, clinical selling approach, and stage, since an early commercial-stage device company needs a different CCO than a scaled one.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
